Literature DB >> 6554031

Laboratory evaluation of the serum dilution test in serious staphylococcal infection.

M J Marcon, R C Bartlett.   

Abstract

Four test media were studied to determine performance characteristics of serum dilution tests used to monitor antimicrobial therapy during serious Staphylococcus aureus infection being treated with highly protein-bound antibiotics. Serum inhibitory titers and serum bactericidal titers obtained with Mueller-Hinton broth supplemented with calcium and magnesium were 3- to 16-fold higher than titers obtained with whole human serum buffered with N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES). In cation-supplemented Mueller-Hinton containing 5% albumin or in cation-supplemented Mueller-Hinton combined with an equal volume of human serum, titers were 2- to 5-fold higher than in whole human serum buffered with HEPES. Clinical or animal studies are needed to establish whether the higher titers observed with patient serum containing highly protein-bound drugs diluted in low protein-content media would foster inadequate dosage regiments. In the meantime, both infectious disease clinicians and microbiologists should be aware of this potential pitfall.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6554031     DOI: 10.1093/ajcp/80.2.176

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  3 in total

1.  Effects of supraphysiologic temperature and broth dilution on serum protein binding.

Authors:  R L White; M B Kays; T A Armstrong; L V Friedrich
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

Review 2.  Serum bactericidal test.

Authors:  C W Stratton
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

Review 3.  Standardization of the serum bactericidal test and its relationship to levels of antimicrobial agents.

Authors:  C W Stratton
Journal:  Eur J Clin Microbiol       Date:  1986-02       Impact factor: 3.267

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.